1-3 of 3
Sandra A. Acholonu
Close
Sort by
Journal Articles

Non-Myeloablative Allogeneic Transplantation (NMT) with T-Cell Replete Graft for Relapsed Chemosensitive Follicular Lymphoma (FL): Donor Lymphocyte Infusion (DLI) To Convert Stable Mixed Chimerism to Full Donor Chimerism Is Not Necessary in the Absence of Disease Progression.

Issa F. Khouri, MD, Ming-Sheng Lee, MD, Rima M. Saliba, PhD, Sandra A. Acholonu, Rosamar Valverde, Martin J. Korbling, MD, Ricahrd E. Champlin, MD
Journal: Blood
Blood (2005) 106 (11): 3659.
https://doi.org/10.1182/blood.V106.11.3659.3659
Published: 2005
Journal Articles

Autologous Stem Cell (AUTO) vs Non-Myeloablative Allogeneic Transplantation (NMT) after High-Dose Rituximab (HD-R) -Containing Conditioning Regimens for Relapsed Chemosensitve Follicular Lymphoma (FL).

Issa F. Khouri, MD, Rima M. Saliba, PhD, Chitra M. Hosing, MD, Sandra A. Acholonu, MPH, Luis E. Fayad, MD, Martin J. Korbling, MD, Celina Saenz, BS, Barbara Pro, MD, Barry I. Samuels, MD, Marcos J. de Lima, MD, Sergio A. Giralt, MD, Anas Younes, MD, Peter W. McLaughlin, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2005) 106 (11): 48.
https://doi.org/10.1182/blood.V106.11.48.48
Published: 2005
Journal Articles

Immunotherapy with Donor Leukocyte Infusions (DLIS) in Relapsed Hodgkin’s Disease (HD) Following Allogeneic Stem Cell Transplantation (ALLO-SCT): CD3+ Cell Dose, GVHD and Disease Response.

Paolo Anderlini, M.D., Sandra A. Acholonu, Grace-Julia Okoroji, Rima Saliba, Sergio A. Giralt, Naoto Ueno, Michele L. Donato, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2004) 104 (11): 1654.
https://doi.org/10.1182/blood.V104.11.1654.1654
Published: 2004